Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
---|
04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
04/28/2009 | US7524846 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
04/28/2009 | CA2259922C Calcium receptor active compounds |
04/23/2009 | WO2009052191A1 Internally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
04/23/2009 | WO2009051460A2 Peptide coupled ascorbic acid derivatives |
04/23/2009 | WO2009050197A2 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
04/23/2009 | WO2009049837A1 Process for preparing 8-hydrazino-8-aryloctanoyl derivatives and their use |
04/23/2009 | WO2009030512A3 Hydroxymethylfurfural ethers and esters prepared in ionic liquids |
04/23/2009 | WO2009030508A3 Hydroxymethylfurfural ethers from sugars or hmf and mixed alcohols |
04/23/2009 | WO2008151170A3 Process for the synthesis of ramelteon and its intermediates |
04/23/2009 | WO2003025192A3 Membrane transportable fluorescent substrates |
04/23/2009 | US20090105490 Polymorphic forms of ramelteon and processes for preparation thereof |
04/23/2009 | US20090105474 Novel anthranilic acid derivative or salt thereof |
04/23/2009 | US20090105332 Processes of making sesquiterpenoid tashironin, its analogs and their uses |
04/23/2009 | US20090105257 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40 |
04/23/2009 | US20090105241 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
04/23/2009 | US20090104711 Fluorescent marker comprising double bond ester group and method for marking and detecting the same |
04/23/2009 | US20090104140 1-oxaspiro (4, 5) dec-3-ene derivatives as perfuming ingredients |
04/22/2009 | EP2050742A1 Method for the synthesis of organic acid esters of 5-hydroxymethylfurfural and their use |
04/22/2009 | EP2049509A2 New furyl thioalkanals useful in the flavor industry |
04/22/2009 | EP1795527B1 Carbamoyl-substituted spiro derivative |
04/22/2009 | EP1585757A4 Peptide deformylase inhibitors |
04/22/2009 | EP1548014B1 Ultraviolet-permeable fluoropolymers and pellicles made by using the same |
04/22/2009 | EP1395539B1 A method for isolating phenolic substances or juvabiones from wood comprising knotwood |
04/22/2009 | EP1381366B1 Indole, azaindole and related heterocyclic amidopiperazine derivatives |
04/22/2009 | CN101415700A Active ingredient combinations with insecticidal properties |
04/22/2009 | CN101415698A Fungicide n-cyclopropyl-sulfonylamide derivatives |
04/22/2009 | CN101412702A Method for preparing chiral dihydrobenzofuran compounds and catalyst used thereby |
04/21/2009 | US7521584 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
04/21/2009 | US7521570 Medicinal compositions containing 6-hydroxybenzbromarone or salts thereof |
04/21/2009 | US7521569 Process to obtain dibenzylbutyrolactonic lignans, process to obtain synthetic derivatives from lignans bearing anti-Chagas chemoprophylactic and therapeutical activities |
04/21/2009 | US7521545 Diazo coupling benzediazonium salt having nitro group at the p- and/or o-position with 2,3-dihydrobenzofuran derivative to produce compounds such as 1-(4-Nitrophenyl)-2-[2,2,4,6,7-pentamethyl-3-(4-methylphenyl)-2,3-dihydro-1-benzofuran-5-yl]diazene; chemical intermediates; efficient, easy and simple |
04/21/2009 | US7521476 Aminoacetonitrile derivatives suitable for controlling parasites |
04/21/2009 | US7521461 2-{[4-(2-Oxo-2-{[4-(trifluoromethyl)benzyl]amino)ethyl)phenoxy]methyl}benzoic acid; peroxisome proliferator activated receptors alpha and gamma agonist; antidiabetic agents; Insulin Resistance Syndrome (IRS); cardiovascular disorders; myocardial infarction; stroke; atherosclerosis; dyslipidemia |
04/21/2009 | US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
04/21/2009 | CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents |
04/16/2009 | WO2009049180A2 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
04/16/2009 | WO2009048564A2 Modified colored pigments |
04/16/2009 | WO2009048274A2 Benzofuran and benzothiophene derivatives substituted with amide, process for the preparation thereof, and pharmaceutical compositions containing the same |
04/16/2009 | WO2009048152A2 Unsaturated imine compound and use thereof for pest control |
04/16/2009 | WO2009047568A2 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells |
04/16/2009 | WO2009047258A1 Bicyclic campholenic derivatives |
04/16/2009 | WO2009047152A1 Sulphonium salt initiators |
04/16/2009 | WO2009047105A1 Sulphonium salt initiators |
04/16/2009 | WO2008124571A3 Anti-viral compounds, compositions and methods |
04/16/2009 | WO2003082205A3 Compounds and methods |
04/16/2009 | US20090099375 process for the preparation of escitalopram |
04/16/2009 | US20090099061 Synthesis of carotenoid analogs or derivatives with improved antioxidant characteristics |
04/16/2009 | US20090095628 Cleavable surfactants |
04/16/2009 | US20090095200 Modified colored pigments |
04/16/2009 | DE202008016372U1 Vitamin enthaltende Zusammensetzung Vitamin-containing composition |
04/16/2009 | DE102007049039A1 Verfahren zur Herstellung von 8-Hydrazino-8-Aryl-Octanoylderivaten und deren Verwendung Process for the preparation of 8-hydrazino-8-aryl-Octanoylderivaten and their use |
04/16/2009 | CA2702182A1 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells |
04/16/2009 | CA2701946A1 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
04/15/2009 | EP2048139A1 PROCESS FOR PRODUCTION OF (±)-3a,6,6,9a TETRAMETHYLDECAHYDRONAPHTHO[2,1-b]FURAN-2(1H)-ONE |
04/15/2009 | EP2047758A1 Bicyclic campholenic derivatives |
04/15/2009 | EP2046714A2 Therapeutic compounds |
04/15/2009 | EP1694641B1 Prostaglandin synthesis |
04/15/2009 | EP1590492B1 Tanning agents and preservatives |
04/15/2009 | EP1432680B1 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
04/15/2009 | EP1385816B1 Method for purifying an organic solvent for the purpose of absorption of maleic acid anhydride |
04/15/2009 | CN101410120A 抗炎的膦酸酯化合物 Phosphonate compound anti-inflammatory |
04/15/2009 | CN101407506A Benzofuran derivatives and uses thereof |
04/15/2009 | CN101407505A Antivirus andrographolide derivative and preparation thereof |
04/15/2009 | CN101407476A M-bis(arene) polysubstituted amino benzene compound as non-nucleoside HIV reverse transcriptase inhibitor, and preparation and use thereof |
04/15/2009 | CN100478336C Derivative of methyol series of andrographolide C15 |
04/15/2009 | CN100477995C Fortifier |
04/14/2009 | US7517992 (-)-cis-1-(5-(4-fluorophenoxy)-pyridin-2-yl)-3-(4,7-difluoro-1,1a,2,7b-tetrahydro-cyclopropa[c]chromene-1-yl)-urea; improved resistance and pharmacokinetic profile; polymerase inhibitors; potent against virus comprising drug escape mutations |
04/14/2009 | US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase |
04/14/2009 | US7517879 Pyrrolidine derivatives as factor Xa inhibitors |
04/14/2009 | US7517471 And benzo[1,2-b:3,4-b']difuran derivatives; liquid crystal media, electrooptical displays; negative Delta epsilon, vertically alligned thin film transistors |
04/14/2009 | CA2253211C Sulfonamide-substituted fused 5-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them |
04/14/2009 | CA2227891C Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations |
04/09/2009 | WO2009046308A1 Intermediates and methods for the synthesis of halichondrin b analogs |
04/09/2009 | WO2009044143A2 Process for preparing benzofurans |
04/09/2009 | WO2009022311A3 1,2-diamido-ethylene derivatives as orexin antagonists |
04/09/2009 | WO2009016218A3 Fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives |
04/09/2009 | WO2008142379A3 Process for the preparation of escitalopram via desmethylcitalopram, optical resolution and methylation of the s-isomer |
04/09/2009 | WO2005041684A3 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
04/09/2009 | US20090093641 Synthesis of Pentafluorosulfanyl (SF5)-Substituted Heterocycles and Alkynes |
04/09/2009 | US20090093638 Allylic Oxidations Catalyzed by Dirhodium Catalysts under Aqueous Conditions |
04/09/2009 | US20090093485 Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases |
04/09/2009 | US20090093459 2-alkoxy-3,4,5-trihydroxyalkylamide-benzothiazepines preparation thereof, compositions containing them and use thereof |
04/09/2009 | DE4448032B4 Zusammensetzung enthaltend organische Materialien und 3-Aryl-benzofuranone als Stabilisatoren A composition comprising organic materials and 3-aryl-benzofuranones as stabilizers |
04/09/2009 | CA2701534A1 Intermediates and methods for the synthesis of halichondrin b analogs |
04/08/2009 | EP2045014A1 Polymer-supported metal complex catalyst |
04/08/2009 | EP2044047A1 Naphthofuranone derivatives as specific inhibitors of thymidylate synthases |
04/08/2009 | EP2044046A2 Substituted n-acyl homoserine lactones |
04/08/2009 | EP2044016A2 4-heteroaryl-substituted 1-aminocyclohexane-1-and cyclohexene-1-derivatives having effects on the opiod receptor system |
04/08/2009 | EP2044004A2 Benzamide derivatives as modulators of 11beta-hsd1 for treating diabetes and obesity |
04/08/2009 | EP2043993A2 Cyclopentane derivatives as antiglaucoma agents |
04/08/2009 | EP2043444A1 Chemical compounds |
04/08/2009 | EP1415986B1 Spiro isobenzofuranes as neuropeptide y receptor antagonists |
04/08/2009 | CN101405889A Organic electroluminescence element material and organic electroluminescence element using such material |
04/08/2009 | CN101405263A Cannibinoid receptor modulators |
04/08/2009 | CN101405259A Process for production of ethylenediamine derivative having halogenated carbamate group and acyl group, and intermediated for production of the derivative |
04/08/2009 | CN101404994A Agent for prevention/treatment of irritable bowel syndrome |
04/08/2009 | CN101402658A Method for thermal degradation of cellulose with ion liquid solvent catalysis |
04/08/2009 | CN101402649A Fatty acid aluminium isopropoxide, preparation method and application thereof |